Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Roche, Boehringer tap biosensor firms for patient studies

A new dawn of the genomic age: five areas set to be transformed in 2023

ABPI code updated with first social media guidance

NICE recommends first CAR-T cell therapy on NHS in England

EU clears Enhertu for HER2-low breast cancer

F2G

F2G_logo

News/ News/ R&D

Novo-backed $61m fundraising helps F2G prep for antifungal launch

Phil Taylor antifungal, antifungal resistance, F2G, financing, infectious disease, Novo Holdings 0 Comment

Anglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening

X

Novo-backed $61m fundraising helps F2G prep for antifungal launch

https://pharmaphorum.com/news/novo-backed-61m-fundraising-helps-f2g-prep-for-antifungal-launch/

FDA tags F2G’s olorofim as Breakthrough Therapy for fungal infections

News/ News/ R&D

FDA tags F2G’s olorofim as Breakthrough Therapy for fungal infections

Richard Staines F2G, fda, R&D 0 Comment

The US drugs regulator has tagged F2G’s olorofim as a potential Breakthrough Therapy for life-threatening fungal infections, pledging

X

FDA tags F2G’s olorofim as Breakthrough Therapy for fungal infections

https://pharmaphorum.com/news/fda-tags-f2gs-olorofilm-as-breakthrough-therapy-for-mould-infections/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

ALS drug tofersen will face FDA advisors, says Biogen
Amazon unveils $5 subscription service for generics
NICE recommends first CAR-T cell therapy on NHS in England
Lilly injects $450m into plant making Mounjaro
Call to arms as UK falls back in medicines manufacturing

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2023

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com